BCAB vs REG · $5.9M cap vs P/E 34, $12.93B cap
Bioatla Inc (BCAB) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
REG does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the BCAB and REG stock pages for the full models.
Not investment advice.